azomycin has been researched along with Leukemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreeff, M; Bankson, JA; Benito, J; Bhattacharya, PK; Cortes, JE; Davis, RE; Hart, CP; Harutyunyan, KG; Jacamo, R; Konoplev, S; Konopleva, M; Lee, J; Lu, H; Ma, H; Marszalek, JR; Matre, P; McQueen, T; Millward, NZ; Mu, H; Protopopova, M; Ramirez, MS; Shi, YX; Velez, J; Volgin, A | 1 |
| Andreeff, M; Badar, T; Benito, JM; Borthakur, G; Cortes, JE; Faderl, S; Handisides, DR; Harutyunyan, K; Jabbour, E; Kantarjian, HM; Konoplev, S; Konopleva, M; Kroll, S; Pearce, T; Richie, MA; Thomas, DA | 1 |
| Bayo, R; Ceraso, D; De Rissio, A; Dengra, C; Dictar, M; Koziner, B; Luna, C; Riarte, A; Segura, E; Sinagra, A; Verón, MT | 1 |
1 trial(s) available for azomycin and Leukemia
| Article | Year |
|---|---|
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
Topics: Adult; Aged; Bone Marrow; Esophagitis; Female; Humans; Hyperbilirubinemia; Hypoxia; Leukemia; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Nitroimidazoles; Phosphoramide Mustards; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prodrugs; Salvage Therapy; Stomatitis; Young Adult | 2016 |
2 other study(ies) available for azomycin and Leukemia
| Article | Year |
|---|---|
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Line, Tumor; Disease Models, Animal; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Hypoxia; Leukemia; Magnetic Resonance Imaging; Mice; Nitroimidazoles; Phosphoramide Mustards; Prodrugs; Treatment Outcome; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2016 |
Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia.
Topics: Adult; Bone Marrow Transplantation; Chagas Disease; Chronic Disease; Female; Humans; Immunosuppression Therapy; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nitroimidazoles; Parasitemia; Recurrence; Transplantation, Autologous; Transplantation, Homologous; Trypanocidal Agents | 1998 |